Does ETANERCEPT Cause Second primary malignancy? 14 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Second primary malignancy have been filed in association with ETANERCEPT (ENBREL). This represents 0.0% of all adverse event reports for ETANERCEPT.
14
Reports of Second primary malignancy with ETANERCEPT
0.0%
of all ETANERCEPT reports
4
Deaths
7
Hospitalizations
How Dangerous Is Second primary malignancy From ETANERCEPT?
Of the 14 reports, 4 (28.6%) resulted in death, 7 (50.0%) required hospitalization, and 5 (35.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ETANERCEPT Cause?
Drug ineffective (60,367)
Rheumatoid arthritis (33,166)
Pain (31,961)
Arthralgia (27,429)
Injection site pain (24,717)
Off label use (20,178)
Fatigue (19,907)
Joint swelling (18,462)
Injection site erythema (17,736)
Condition aggravated (15,897)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which ETANERCEPT Alternatives Have Lower Second primary malignancy Risk?
ETANERCEPT vs ETANERCEPT-SZZS
ETANERCEPT vs ETELCALCETIDE
ETANERCEPT vs ETEPLIRSEN
ETANERCEPT vs ETESEVIMAB
ETANERCEPT vs ETHACRYNIC ACID